OneSource Specialty Pharma Limited announced receipt of an independent Environmental, Social, and Governance (ESG) score of 65.7 assigned by SES ESG Research Private Limited. This rating is based on FY 2024-25 public data and was received by the company on February 11, 2026. Importantly, the company noted that it had not engaged SES ESG for the preparation of this report.
Disclosure of Independent ESG Rating
OneSource Specialty Pharma Limited formally informed stock exchanges regarding the assignment of an ESG rating by SES ESG Research Private Limited. The company received the report on February 11, 2026.
The resulting Environmental, Social, and Governance (ESG) score assigned to the company is 65.7. This score is derived from data pertaining to the financial year FY 2024-25 that was available in the public domain.
Nature of Engagement
The company explicitly stated that it had not engaged SES ESG Research Private Limited for the purpose of obtaining this ESG Rating. The report was independently prepared by SES based solely on publicly available data concerning OneSource Specialty Pharma Limited.
Compliance Acknowledgement
This intimation is made in compliance with applicable disclosure regulations. The company confirmed that this notice is in accordance with master circular references dated January 30, 2026. The information is now officially recorded by the exchange following the disclosure made on February 12, 2026.
Source: BSE
